Also known as Arixtra
Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories.Source: Wikipedia
Estimated Total Cost: $1244.77 for an average of 14 days supply
Patients are most commonly prescribed fondaparinux to treat deep vein thrombosis (dvt), pulmonary embolism, blastomycosis, and rabies.